Dossier
drug industry
Coverage of drug industry in the Nexus archive.
- Why is the US targeting Germany's drug industry?
A new trade probe by the US is reigniting a dispute over cost distribution for medical innovation, with Washington claiming Germany benefits from lower drug prices while US patients cover higher costs.
- STAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur says
Rick Pazdur, former top oncology regulator at the Food and Drug Administration, stated that recent political appointees have caused significant damage, creating an opportunity for new leadership to restructure the FDA. He highlighted the growing competitiveness of China's drug industry and proposed creative workforce solutions, such as temporarily hiring academics and drug industry professionals.